Skip to main content

Table 2 Uni- and multivariable Cox regression analyses for DFS in the discovery cohort and validation cohort

From: Automated whole-slide images assessment of immune infiltration in resected non-small-cell lung cancer: towards better risk-stratification

Variables

Discovery cohort

 

Validation cohort

Univariable analysis

Multivariable analysisa

 

Univariable analysis

Multivariable analysisa

Unadjusted HRb

(95% CI)

P

Adjusted HRc

(95% CI)

P

 

Unadjusted HRb

(95% CI)

P

Adjusted HRc

(95% CI)

P

Age at surgery (years)

         

  ≥ 65 vs. < 65

1.13 (0.70–1.82)

0.624

   

1.00 (0.58–1.73)

0.991

  

Sex

         

  Female vs. male

0.63 (0.39–1.03)

0.067

   

0.58 (0.36–0.94)

0.026

  

Smoking status

         

  Former/current vs. never

1.08 (0.66–1.78)

0.748

   

1.18 (0.76–1.84)

0.469

  

TNM stage

         

  Stage II vs. stage I

3.82 (1.99–7.34)

 < 0.001

2.41 (1.13–5.18)

0.024

 

2.95 (1.68–5.18)

 < 0.001

2.87 (1.64–5.06)

 < 0.001

  Stage III vs. stage I

5.69 (3.33–9.73)

 < 0.001

2.84 (1.33–6.06)

0.007

 

3.62 (2.15–6.09)

 < 0.001

3.23 (1.91–5.48)

 < 0.001

Differentiation grade

         

  G3/G4 vs. G1/G2

2.79 (1.72–4.52)

 < 0.001

1.68 (1.01–2.82)

0.047

 

1.56 (1.00–2.43)

0.050

  

Surgical resection

         

  Limited resection vs.

lobectomy/pneumonectomy

1.37 (0.63–2.99)

0.429

   

1.56 (0.49–4.94)

0.451

  

Adjuvant chemotherapy

         

  Yes vs. no

3.83 (2.38–6.15)

 < 0.001

1.77 (0.91–3.41)

0.090

 

2.23 (1.35–3.68)

0.002

  

I-score (three-category)

         

  Intermediate vs. low

0.79 (0.42–1.46)

0.447

   

1.05 (0.57–1.96)

0.867

  

  High vs. low

0.44 (0.25–0.78)

0.005

   

0.49 (0.26–0.93)

0.029

  

I-score (two-category)

         

  High vs. low

0.51 (0.32–0.81)

0.004

0.57 (0.36–0.92)

0.022

 

0.47 (0.30–0.75)

0.001

0.54 (0.33–0.86)

0.010

  1. Data in parentheses are 95% confidence intervals
  2. DFS  disease-free survival, HR hazard ratio, CI  confidence interval
  3. aVariables that reach statistical significance at P < 0.10 in the univariable analysis (sex, TNM stage, differentiation grade, adjuvant chemotherapy, two-category I-score) are included in the multivariable analysis
  4. bThe unadjusted hazard ratios (HR) and P-values are determined by univariable Cox regression analyses
  5. cThe adjusted hazard ratios (HR) and P-values are determined by multivariable Cox regression analyses